Increased risk of breast cancer in women bearing a combination of large CAG and GGN repeats in the exon 1 of the androgen receptor gene

European Journal of Cancer

Volumn 43, Issue 16, 2007, Pages 2373-2380

  González, Ana ^a,b   Javier Dorta, F ^a,b   Rodriguez, Germán ^a,c   Brito, Buenaventura ^a,b   Rodríguez, Ma del Cristo ^a,b   Cabrera, Antonio ^a,d   Díaz Chico, Juan C ^a,c   Reyes, Ricardo ^a,b   Aguirre Jaime, Armando ^a,b   Nicolas Diaz Chico B ^a,c  

^a Madrid Spain   (Spain)

^b HOSPITAL UNIVERSITARIO NUESTRA SEÑORA DE CANDELARIA   (Spain)

^c UNIVERSITY OF LAS PALMAS DE GRAN CANARIA   (Spain)

^d UNIVERSIDAD DE LA LAGUNA   (Spain)

Author keywords

Androgen receptor; Androgens; Breast cancer; CAG polymorphism; GGN polymorphism

Indexed keywords

ANDROGEN RECEPTOR; POLYGLUTAMINE;

ADULT; ALLELE; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER RISK; CANCER STAGING; CONTROLLED STUDY; DNA POLYMORPHISM; EXON; FEMALE; GENETIC ANALYSIS; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ADULT; AGED; ALLELES; BREAST NEOPLASMS; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTORS, ANDROGEN; RISK FACTORS;

EID: 35448971079     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2007.07.001     Document Type: Article

References (42)

1. Labrie F., Luu-The V., Labrie C., et al. Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone. Endocr Rev 24 (2000) 152-182
2. Kaaks R., Berrino F., Key T., et al. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC). J Natl Cancer Inst 97 (2005) 755-765
3. Kaaks R., Rinaldi S., Key T.J., et al. Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition. Endocr Relat Cancer 12 (2005) 1071-1082
4. Brodie A., Lu Q., and Nakamura J. Aromatase in the normal breast and breast cancer. J Steroid Biochem Mol Biol 61 (1997) 281-286
5. Hackenberg R., Turgetto I., Filmer A., and Schulz K.D. Estrogen and androgen receptor mediated stimulation and inhibition of proliferation by androst-5-ene-3 beta,17 beta-diol in human mammary cancer cells. J Steroid Biochem Mol Biol 46 (1993) 597-603
6. Gao T., Marcelli M., and McPhaul M.J. Transcriptional activation and transient expression of the human androgen receptor. J Steroid Biochem Mol Biol 59 (1996) 9-20
7. Hall R.E., Clements J.A., Birrell S.N., and Tilley W.D. Prostate-specific antigen and gross cystic disease fluid protein-15 are co-expressed in androgen receptor-positive breast tumours. Br J Cancer 78 (1998) 360-365
8. Somboonporn W., and Davis S.R. National Health and Medical Research Council. Testosterone effects on the breast: implications for testosterone therapy for women. Endocr Rev 25 (2004) 374-388
9. Chamberlain N.L., Driver E.D., and Miesfeld R.L. The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Res 22 (1994) 3181-3186
10. Beilin J., Ball E.M., Favaloro J.M., and Zajac J.D. Effect of the androgen receptor CAG repeat polymorphism on transcriptional activity: specificity in prostate and non-prostate cell lines. J Mol Endocrinol 25 (2000) 85-96
11. La Spada A.R., Wilson E.M., Lubahn D.B., Harding A.E., and Fischbeck K.H. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 352 (1991) 77-79
12. Sleddens H.F., Oostra B.A., Brinkmann A.O., and Trapman J. Trinucleotide (GGN) repeat polymorphism in the human androgen receptor (AR) gene. Hum Mol Genet 2 (1993) 493
13. Ding D., Xu L., Menon M., Reddy G.P., and Barrack E.R. Effect of GGC (glycine) repeat length polymorphism in the human androgen receptor on androgen action. Prostate 62 (2005) 133-139
14. Aschim E.L., Nordenskjold A., Giwercman A., et al. Linkage between cryptorchidism, hypospadias, and GGN repeat length in the androgen receptor gene. J Clin Endocrinol Metab 89 (2004) 5105-5109
15. Zeegers M.P., Kiemeney L.A., Nieder A.M., and Ostrer H. How strong is the association between CAG and GGN repeat length polymorphisms in the androgen receptor gene and prostate cancer risk?. Cancer Epidemiol Biomarkers Prev 13 (2004) 1765-1771
16. McGrath M., Lee I.M., Hankinson S.E., et al. Androgen receptor polymorphisms and endometrial cancer risk. Int J Cancer 118 (2006) 1261-1268
17. Rodriguez G., Bilbao C., Ramirez R., et al. Alleles with short CAG and GGN repeats in the androgen receptor gene are associated with benign endometrial cancer. Int J Cancer 118 (2006) 1420-1425
18. Terry K.L., De Vivo I., Titus-Ernstoff L., Shih M.C., and Cramer D.W. Androgen receptor cytosine, adenine, guanine repeats, and haplotypes in relation to ovarian cancer risk. Cancer Res 65 (2005) 5974-5981
19. Slattery M.L., Sweeney C., Murtaugh M., et al. Associations between ERalpha, ERbeta, and AR genotypes and colon and rectal cancer. Cancer Epidemiol Biomarkers Prev 14 (2005) 2936-2942
20. Dietzsch E., Laubscher R., and Parker M.I. Esophageal cancer risk in relation to GGC and CAG trinucleotide repeat lengths in the androgen receptor gene. Int J Cancer 107 (2003) 38-45
21. Lillie E.O., Bernstein L., and Ursin G. The role of androgens and polymorphisms in the androgen receptor in the epidemiology of BC. BC Res 5 (2003) 164-173
22. Liede A., Zhang W., De Leon Matsuda M.L., Tan A., and Narod S.A. Androgen receptor gene polymorphism and BC susceptibility in The Philippines. Cancer Epidemiol Biomarkers Prev 12 (2003) 848-852
23. Giguere Y., Dewailly E., Brisson J., et al. Short polyglutamine tracts in the androgen receptor are protective against breast cancer in the general population. Cancer Res 61 (2001) 5869-5874
24. Rebbeck T.R., Kantoff P.W., Krithivas K., et al. Modification of BRCA1-associated BC risk by the polymorphic androgen-receptor CAG repeat. Am J Hum Genet 64 (1999) 1371-1377
25. Menin C., Banna G.L., De Salvo G., et al. Lack of association between androgen receptor CAG polymorphism and familial breast/ovarian cancer. Cancer Lett 168 (2001) 31-36
26. Kadouri L., Easton D.F., Edwards S., et al. CAG and GGC repeat polymorphisms in the androgen receptor gene and BC susceptibility in BRCA1/2 carriers and non-carriers. Br J Cancer 85 (2001) 36-40
27. Elhaji Y.A., Gottlieb B., Lumbroso R., et al. The polymorphic CAG repeat of the androgen receptor gene: a potential role in BC in women over 40. BC Res Treat 70 (2001) 109-116
28. Haiman C.A., Brown M., Hankinson S.E., et al. The androgen receptor CAG repeat polymorphism and risk of BC in the Nurses' Health Study. Cancer Res 62 (2002) 1045-1049
29. Dagan E., Friedman E., Paperna T., Carmi N., and Gershoni-Baruch R. Androgen receptor CAG repeat length in Jewish Israeli women who are BRCA1/2 mutation carriers: association with breast/ovarian cancer phenotype. Eur J Hum Genet 10 (2002) 724-728
30. Suter N.M., Malone K.E., Darling J.R., Doody D.R., and Ostrander E.A. Androgen receptor (CAG)n and (GGC)n polymorphisms and BC risk in a population-based case-control study of young women. Cancer Epidemiol Biomarkers Prev 12 (2003) 127-135
31. Spurdle A.B., Dite G.S., Chen X., et al. Androgen receptor exon 1 CAG repeat length and breast cancer in women before age forty years. J Natl Cancer Inst 91 (1999) 961-966
32. Spurdle A.B., Antoniou A.C., Duffy D.L., et al. The androgen receptor CAG repeat polymorphism and modification of breast cancer risk in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res 7 (2005) R176-R183
33. Dunning A.M., McBride S., Gregory J., et al. No association between androgen or vitamin D receptor gene polymorphisms and risk of BC. Carcinogenesis 20 (1999) 2131-2135
34. Bharaj B.S., Vassilikos E.J., and Diamandis E.P. Rapid and accurate determination of (CAG)n repeats in the androgen receptor gene using polymerase chain reaction and automated fragment analysis. Clin Biochem 32 (1999) 327-332
35. Kittles R.A., Young D., Weinrich S., et al. Extent of linkage disequilibrium between the androgen receptor gene CAG and GGC repeats in human populations: implications for prostate cancer risk. Hum Genet 109 (2001) 253-261
36. Sasaki M., Kaneuchi M., Sakuragi N., Fujimoto S., Carroll P.R., and Dahiya R. The polyglycine and polyglutamine repeats in the androgen receptor gene in Japanese and Caucasian populations. Biochem Biophys Res Commun 312 (2003) 1244-1247
37. MacLean H.E., Brown R.W., Beilin J., Warne G.L., and Zajac J.D. Increased frequency of long androgen receptor CAG repeats in male breast cancers. Breast Cancer Res Treat 88 (2004) 239-246
38. Wang W., John E.M., and Ingles S.A. Androgen receptor and prostate-specific antigen gene polymorphisms and BC in African-American women. Cancer Epidemiol Biomarkers Prev 14 (2005) 2990-2994
39. Iobagiu C., Lambert C., Normand M., and Genin C. Microsatellite profile in hormonal receptor genes associated with BC. BC Res Treat 95 (2006) 153-159
40. Hsing A.W., Gao Y.T., Wu G., et al. Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: a population-based case-control study in China. Cancer Res 60 (2000) 5111-5116
41. Stanford J.L., Just J.J., Gibbs M., et al. Polymorphic repeats in the androgen receptor gene: molecular markers of prostate cancer risk. Cancer Res 57 (1997) 1194-1198
42. Yu H., Bharaj B., Vassilikos E.J., Giai M., and Diamandis E.P. Shorter CAG repeat length in the androgen receptor gene is associated with more aggressive forms of BC. BC Res Treat 59 (2000) 153-161